Germinal center-derived broadly neutralizing antibodies adapt to SARS-CoV-2 antigenic drift
K. Shitaoka, Y. Kawano, A. Higashiura, Y. Mizoguchi, T. Hashiguchi, N. Nishimichi, S. Huang, A. Ito, A. Yamamoto, S. Ohki, M. Kanda, T. Taniguchi, Y. Yokosaki, S. Okada, T. Sakaguchi, T. Yasuda
The paper identifies neutralizing antibodies from early SARS-CoV-2 infections that retain activity against Omicron and other variants, highlighting the role of germinal center mutations in their broad neutralization.
bioRxiv · Jan 26, 2022 · PreprintImmunology